Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 840

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Lymphatic mapping and sentinel lymph node biopsy in early‐stage breast carcinoma: A metaanalysis

Open access
Kim, Theodore, Giuliano, Armando E., Lyman, Gary H.·2006·Cancer

Abstract

BACKGROUND: Lymphatic mapping with sentinel lymph node biopsy has the potential for reducing the morbidity associated with breast carcinoma staging. It has become a widely used technology despite limited data from controlled clinical trials. METHODS: A systematic review of the world's literature of sentinel lymph node (SLN) biopsy in patients with early‐stage breast carcinoma was undertaken by using electronic and hand searching techniques. Only studies that incorporated full axillary lymph node dissection (ALND), regardless of SLN results, were included. Individual study results along with weighted summary measures were estimated using the Mantel–Haenszel method. The correlations of outcomes with the study size, the proportion of positive lymph nodes, the technique used, and the study quality were evaluated. RESULTS: Between 1970 and 2003, 69 trials were reported that met eligibility criteria. Of the 8059 patients who were studied, 7765 patients (96%) had successfully mapped SLNs. The proportion of patients who had successfully mapped SLNs ranged from 41% to 100%, with > 50% of studies reporting a rate < 90%. Lymph node involvement was found in 3132 patients (42%) and ranged from 17% to 74% across studies. The false‐negative rate (FNR) ranged from 0% to 29%, averaging 7.3% overall. Eleven trials (15.9%) reported an FNR of 0.0, whereas 26 trials (37.7%) reported an FNR > 10%. Significant inverse correlations were observed between the FNR and both the number of patients studied ( r = − 0.42; P < 0.01) and the proportion of patients who had successfully mapped SLNs nodes ( r = − 0.32; P = 0.009). CONCLUSIONS: Lymphatic mapping with SLN biopsy is used widely to reduce the complications associated with ALND in patients with low‐risk breast carcinoma. This systematic review revealed a wide variation in test performance. Cancer 2006. © 2005 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.21568

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 840

Metadata

Authors
Kim, T., Giuliano, A. E., & Lyman, G. H.
Venue
Cancer
Publisher
Wiley
Published
2005-12-23
Volume
106
Issue
1
Pages
4-16
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2071665160
Cited by
840
References
2
FWCI
10.88
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lymphatic mapping and sentinel lymph node biopsy in early‐stage breast carcinoma: A metaanalysis. https://app.cochat.ai/papers/10.1002/cncr.21568
The paper
Kim, T., Giuliano, A. E., & Lyman, G. H. (2006). Lymphatic mapping and sentinel lymph node biopsy in early‐stage breast carcinoma: A metaanalysis. Cancer. https://doi.org/10.1002/cncr.21568

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.